Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 7:11 pm Sale | 2023-12-31 | 13G | Protara Therapeutics, Inc. TARA | ORBIMED ADVISORS LLC | 0 0.000% | -671,741 (Position Closed) | Filing History |
| 2023-02-14 4:52 pm Unchanged | 2022-12-31 | 13G | Protara Therapeutics, Inc. TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 6:59 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Perceptive Advisors LLC | 421,641 3.800% | -186,903 (-30.71%) | Filing History |
| 2022-02-14 6:27 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Rock Springs Capital Management LP | 0 0.000% | -643,200 (Position Closed) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital, LLC | 279,256 2.500% | -370,286 (-57.01%) | Filing History |
| 2022-02-11 4:40 pm Purchase | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | ORBIMED ADVISORS LLC | 671,741 6.000% | 671,741 (New Position) | Filing History |
| 2021-02-16 4:32 pm Sale | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Rock Springs Capital Management LP | 643,200 5.740% | -422 (-0.07%) | Filing History |
| 2021-02-16 3:38 pm Unchanged | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Perceptive Advisors LLC | 608,544 5.400% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital, LLC | 649,542 5.800% | 649,542 (New Position) | Filing History |
| 2021-01-08 3:32 pm Unchanged | 2021-01-05 | 13D | Protara Therapeutics, Inc. TARA | Deerfield Mgmt, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-10-02 3:38 pm Purchase | 2020-09-22 | 13G | Protara Therapeutics, Inc. TARA | Rock Springs Capital Management LP | 643,622 6.160% | 643,622 (New Position) | Filing History |
| 2020-10-01 4:09 pm Purchase | 2020-09-24 | 13G | Protara Therapeutics, Inc. TARA | Perceptive Advisors LLC | 608,544 5.800% | 608,544 (New Position) | Filing History |